CompletedNot Applicable

Survey on Lymphedema After Sentinel Lymph Node Biopsy in People With Cervical or Vulvar Cancer

United States111 participantsStarted 2022-02-15

Plain-language summary

The purpose of this study is to collect information that may identify people who are at risk of developing lower extremity lymphedema (LEL) after sentinel lymph node biopsy (SLN) during surgery for early-stage vulvar or cervical cancer, and to improve the quality and accuracy of the information that is given to people who have this procedure. Please note that, during this study, the researchers will collect information from a questionnaire completed by people who had SLN and LND+/- SLN during surgery for early-stage cervical or vulvar cancer. No form of treatment will be provided as part of the study, and no investigational tests or procedures will be performed.

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Presented to MSK with newly diagnosed early-stage cervical cancer of any histologic profile or early stage vulvar cancer of any histologic profile. °Early stage: Stage 1-2 * Underwent primary surgery at our institution between January 2006 and January 2022. * Alive at the time of study activation * English comprehension * Capable of providing informed consent Exclusion Criteria: * Had documented macroscopic evidence of metastatic disease at the time of initial diagnosis

What they're measuring

prevalence of patient-reported lower extremity lymphedema

Timeframe: 1 year

Trial details

NCT IDNCT05255393

SponsorMemorial Sloan Kettering Cancer Center

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-11-19

View on ClinicalTrials.gov More Cervical Cancer trials